Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4023825 | Journal Français d'Ophtalmologie | 2012 | 6 Pages |
Abstract
LFV-PDT treatment for patients with long-standing chronic central serous chorioretinopathy results in anatomical and functional improvement (sustained disappearance of the exudative phenomenon in most cases and increased BCVA in more than two-thirds of the cases). The macular atrophy observed may be due to the treatment or the natural course of the disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
P.-L. Cornut, M. Quaranta-El Maftouhi, M. Mauget-Faÿsse,